Daré Bioscience (Cerulean)
AcquiredSan Diego, United States · Founded 2017 · $21.5M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $21.5M
- Last Round
- $11.5M GrantJul 2021
- Rounds
- 2
- Acquisition Date
- Jul 2017
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 6 funding rounds and 3 investors for this company. The full record is or through the API.
About
Women's health biopharmaceutical company developing and commercializing innovative therapies for reproductive health, contraception, and vaginal conditions.
Summary
Daré Bioscience (Cerulean) is a Biotech company based in San Diego, United States, founded in 2017. It has raised $21.5M in total across 2 rounds, most recently a $11.5M Grant round in Jul 2021. Investors include Bill & Melinda Gates Foundation, Lincoln Park Capital and Polaris Partners.
Funding & Exit History
Jul 2021
Sign up to see all 6 events
Funding: Series B through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dar-bioscience-cerulean"><img src="https://indexed.vc/api/badge/company/dar-bioscience-cerulean" alt="Daré Bioscience (Cerulean) on Indexed.vc" width="260" height="76" /></a>
